PIEN HOWARD H

Director at CHIRON CORP · on record since Apr 19, 2006
Director at VIROPHARMA INC · on record since May 23, 2006
Director at ImmunoGen, Inc. · on record since Feb 16, 2007
Director at MEDAREX INC · on record since Jun 22, 2007
Former Director at ImmunoGen, Inc. · on record since May 18, 2007
Director at Vanda Pharmaceuticals Inc. · on record since Jun 7, 2007
Pres., CEO & Chair. of the Brd at MEDAREX INC · on record since Oct 2, 2008
Director at Talon Therapeutics, Inc. · on record since Apr 24, 2012
Director at Sage Therapeutics, Inc. · on record since Jul 17, 2014
Director at Juno Therapeutics, Inc. · on record since Dec 23, 2014
Director at Aceragen, Inc. · on record since Sep 20, 2018
Chairman & CEO at CHIRON CORP · on record since Apr 4, 2005

Insider trading activity of PIEN HOWARD H

Transactions on record: 166; since Feb 17, 2004

Open-market buys: 0

Open-market sells: 8; $300K

Companies traded: 9; last filing Oct 5, 2020

Figures computed from official regulatory filings — .

Companies where PIEN HOWARD H has traded

Aceragen, Inc.11 tx · $95.7K · Oct 5, 2020
Juno Therapeutics, Inc.21 tx · $11.8M · Mar 7, 2018
ImmunoGen, Inc.57 tx · $615K · Jan 3, 2018
Sage Therapeutics, Inc.2 tx · $1.4M · Jun 24, 2016
9 tx · Jun 22, 2015
25 tx · $450K · Jan 28, 2014
4 tx · Jul 18, 2013
25 tx · $27.1M · Sep 3, 2009
12 tx · $17.1M · Apr 19, 2006

Track record of PIEN HOWARD H

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of PIEN HOWARD H

Co-insiders of PIEN HOWARD H

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aceragen, Inc.Listing unverified	Oct 5, 2020	Award	5,583	2.25 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	Jul 2, 2020	Award	7,018	1.79 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	May 19, 2020	AwardD (derivative)	11,500	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Apr 3, 2020	Award	9,666	1.28 USD	$12.4K	SEC
Aceragen, Inc.Listing unverified	Jan 6, 2020	Award	6,790	1.85 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	Oct 2, 2019	Award	4,610	2.67 USD	$12.3K	SEC
Aceragen, Inc.Listing unverified	Jul 2, 2019	Award	4,469	2.61 USD	$11.7K	SEC
Aceragen, Inc.Listing unverified	Jun 6, 2019	AwardD (derivative)	11,500	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Apr 2, 2019	Award	4,392	2.59 USD	$11.4K	SEC
Aceragen, Inc.Listing unverified	Jan 3, 2019	Award	2,929	3.52 USD	$10.3K	SEC
Aceragen, Inc.Listing unverified	Sep 20, 2018	AwardD (derivative)	23,000	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Other	-5,050	87.00 USD	$439.4K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	63.71 USD	$764.5K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	27.00 USD	$324K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	44.60 USD	$535.2K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Gift	-1,162	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Gift	-12,251	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Other	-111,587	87.00 USD	$9.7M	SEC
Juno Therapeutics, Inc.Listing unverified	Jan 9, 2018	Award	417	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Jan 9, 2018	Gift	-25,000	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Jan 3, 2018	AwardD (derivative)	1,033	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Oct 6, 2017	Award	447	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Oct 3, 2017	AwardD (derivative)	882	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Jul 7, 2017	Award	640	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Jul 3, 2017	AwardD (derivative)	949	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Aceragen, Inc.Listing unverified	Oct 5, 2020	Award	5,583	2.25 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	Jul 2, 2020	Award	7,018	1.79 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	May 19, 2020	AwardD (derivative)	11,500	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Apr 3, 2020	Award	9,666	1.28 USD	$12.4K	SEC
Aceragen, Inc.Listing unverified	Jan 6, 2020	Award	6,790	1.85 USD	$12.6K	SEC
Aceragen, Inc.Listing unverified	Oct 2, 2019	Award	4,610	2.67 USD	$12.3K	SEC
Aceragen, Inc.Listing unverified	Jul 2, 2019	Award	4,469	2.61 USD	$11.7K	SEC
Aceragen, Inc.Listing unverified	Jun 6, 2019	AwardD (derivative)	11,500	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Apr 2, 2019	Award	4,392	2.59 USD	$11.4K	SEC
Aceragen, Inc.Listing unverified	Jan 3, 2019	Award	2,929	3.52 USD	$10.3K	SEC
Aceragen, Inc.Listing unverified	Sep 20, 2018	AwardD (derivative)	23,000	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Other	-5,050	87.00 USD	$439.4K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	63.71 USD	$764.5K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	27.00 USD	$324K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	OtherD (derivative)	-12,000	44.60 USD	$535.2K	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Gift	-1,162	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Gift	-12,251	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Mar 7, 2018	Other	-111,587	87.00 USD	$9.7M	SEC
Juno Therapeutics, Inc.Listing unverified	Jan 9, 2018	Award	417	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Jan 9, 2018	Gift	-25,000	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Jan 3, 2018	AwardD (derivative)	1,033	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Oct 6, 2017	Award	447	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Oct 3, 2017	AwardD (derivative)	882	0.00 USD	—	SEC
Juno Therapeutics, Inc.Listing unverified	Jul 7, 2017	Award	640	0.00 USD	—	SEC
ImmunoGen, Inc.Listing unverified	Jul 3, 2017	AwardD (derivative)	949	0.00 USD	—	SEC